uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted November 21, 2015

FTC Charges Maker of Supplement for Opiate Addiction with Deceptive Claims

On November 16, 2015, the FTC filed a lawsuit against Sunrise Nutraceuticals, LLC, charging that the company made deceptive claims its product, Elimidrol, can alleviate opiate withdrawal symptoms and increase a user's likelihood of overcoming opiate addiction. 

Elimidrol contains a "proprietary blend" of herbs and other compounds, including valerian, kava, chamomile, GABA and 5-HTP. It costs $75 for an one 8 oz. bottle. It was promoted on the company's website with claims such as "permanently overcome withdrawal -- the first time" and "guaranteed to work," as well as testimonials such as "I was introduced to Elimidrol and it saved my life. This is not an exaggeration, it SAVED my life.

The FTC stated that claims the product could alleviate symptoms of opiate withdrawal, or increase the likelihood of overcoming addition are unsubstantiated.

See's Reviews of Valerian Supplements and 5-HTP Supplements for tests of related products.

To read the FTC's press release, use the link below.